高龄高危头颈鳞癌术后辅助放化疗:美国国家癌症数据库分析
该研究基于美国国家癌症数据库,分析2004—2012年间接受根治性手术及辅助放疗的高龄(>70岁)头颈鳞癌伴包膜外侵犯或切缘阳性患者的辅助同步放化疗使用模式及总生存关联。
要点
- 高龄(>70岁)头颈鳞癌伴包膜外侵犯或切缘阳性者中,42%接受辅助同步放化疗。
核心结论
- 在高龄头颈鳞癌术后伴包膜外侵犯或切缘阳性患者中,辅助同步放化疗的使用在研究期间增加,多因素分析显示与总生存改善相关,但倾向评分加权分析未达统计学显著。
研究设计与样本
- 基于美国国家癌症数据库(National Cancer Database)的回顾性队列分析,纳入2004—2012年间接受根治性手术及辅助放疗的口腔、口咽、喉、下咽鳞癌患者。
- 研究人群为年龄>70岁、病理示包膜外侵犯或切缘阳性的445例高龄患者,其中187例(42%)接受同步放化疗。
主要发现
- 高龄患者中位随访30.6个月。
- 同步放化疗组3年总生存率为53.8%,单纯辅助放疗组为44.6%。
临床怎么用
- 对于体能状况良好的高龄头颈鳞癌患者,根治性手术后若病理示包膜外侵犯或切缘阳性,可谨慎考虑辅助同步放化疗。
局限性
- 回顾性研究设计,倾向评分加权分析未达统计学显著,结论需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the patterns of adjuvant chemoradiotherapy use in elderly patients treated with definitive surgical resection for squamous cell carcinoma of the head and neck with extracapsular extension (ECE) or positive margins and determine whether an association with overall survival (OS) exists with adjuvant concurrent chemoradiotherapy (CRT). METHODS AND MATERIALS: The National Cancer Database was queried to identify patients with SCC of the oral cavity, oropharynx, larynx, and hypopharynx who were treated with primary definitive surgery and adjuvant radiation therapy between 2004 and 2012. For elderly patients (aged >70 years) with pathology revealing ECE or positive margin, the benefit of concurrent chemotherapy was explored using multivariable Cox proportional hazards modeling. RESULTS: A total of 7349 patients were identified meeting study criteria, of whom 1187 were elderly (aged >70 years) with a median follow-up of 30.6 months. Of these elderly patients, 445 had ECE or positive margin and represent the study population, of whom 187 (42%) received CRT. Delivery of CRT in this cohort increased over the study period, and intensity modulated radiation therapy was associated with increased use of CRT (odds ratio 2.07; P=.004). Increasing age was associated with reduced use of CRT (odds ratio 0.88; P<.001). Chemoradiotherapy was associated with a significant improvement in OS on multivariable analysis (hazard ratio 0.74; P=.04) and a trend toward significance on inverse propensity score analysis (hazard ratio 0.78; P=.051). Three-year OS was 53.8% in the CRT group, compared with 44.6% in the adjuvant radiation therapy-alone patients. CONCLUSIONS: The use of adjuvant CRT is increasing among elderly patients with resected squamous cell carcinoma of the head and neck exhibiting ECE or positive margins. Chemoradiotherapy was associated with an improvement in OS on multivariable analysis but not propensity-weighted analysis. Among fit elderly patients with ECE or positive margins after definitive surgical resection, concurrent chemotherapy can be carefully considered.
引用
- Woody NM, Ward MC, Koyfman SA, et al. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis. Int J Radiat Oncol Biol Phys. 2017. PMID: 28602410. doi:10.1016/j.ijrobp.2017.03.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。